175 related articles for article (PubMed ID: 33388749)
1. Distinct Disease Severity Between Children and Older Adults With Coronavirus Disease 2019 (COVID-19): Impacts of ACE2 Expression, Distribution, and Lung Progenitor Cells.
Zhang Z; Guo L; Huang L; Zhang C; Luo R; Zeng L; Liang H; Li Q; Lu X; Wang X; Ma CY; Shao J; Luo W; Li L; Liu L; Li Z; Zhou X; Zhang X; Liu J; Yang J; Kwan KY; Liu W; Xu Y; Jiang H; Liu H; Du H; Wu Y; Yu G; Chen J; Wu J; Zhang J; Liao C; Chen HJ; Chen Z; Tse HF; Xia H; Lian Q
Clin Infect Dis; 2021 Dec; 73(11):e4154-e4165. PubMed ID: 33388749
[TBL] [Abstract][Full Text] [Related]
2. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
Zhang Z; Guo L; Lu X; Zhang C; Huang L; Wang X; Duan F; Liang H; Chen P; Zeng L; Shao J; Li H; Li L; Liu L; Li C; Zhang J; Ma CY; Kwan KY; Liu W; Xu Y; Gu X; Jiang H; Du H; Zhang T; Wu Y; Yu G; Chen J; Luo R; Liao C; Tse HF; Chen Z; Chen HJ; Xia H; Lian Q
Theranostics; 2021; 11(5):2170-2181. PubMed ID: 33500718
[No Abstract] [Full Text] [Related]
3. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
Möhlendick B; Schönfelder K; Breuckmann K; Elsner C; Babel N; Balfanz P; Dahl E; Dreher M; Fistera D; Herbstreit F; Hölzer B; Koch M; Kohnle M; Marx N; Risse J; Schmidt K; Skrzypczyk S; Sutharsan S; Taube C; Westhoff TH; Jöckel KH; Dittmer U; Siffert W; Kribben A
Pharmacogenet Genomics; 2021 Oct; 31(8):165-171. PubMed ID: 34001841
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.
Ortiz ME; Thurman A; Pezzulo AA; Leidinger MR; Klesney-Tait JA; Karp PH; Tan P; Wohlford-Lenane C; McCray PB; Meyerholz DK
EBioMedicine; 2020 Oct; 60():102976. PubMed ID: 32971472
[TBL] [Abstract][Full Text] [Related]
5. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression of the SARS-CoV-2 cell receptor gene ACE2 in children.
Huang J; Guo Z; Duan J; Zou Y; Chen K; Huang H; Zhang S; Zhou Y
J Trop Pediatr; 2023 Sep; 69(5):. PubMed ID: 37674390
[TBL] [Abstract][Full Text] [Related]
7. Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome.
Gerard L; Lecocq M; Bouzin C; Hoton D; Schmit G; Pereira JP; Montiel V; Plante-Bordeneuve T; Laterre PF; Pilette C
Am J Respir Crit Care Med; 2021 Nov; 204(9):1024-1034. PubMed ID: 34449302
[No Abstract] [Full Text] [Related]
8. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis.
Soni S; Jiang Y; Tesfaigzi Y; Hornick JL; Çataltepe S
PLoS One; 2021; 16(2):e0247510. PubMed ID: 33626084
[TBL] [Abstract][Full Text] [Related]
10. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets.
Babadaei MMN; Hasan A; Bloukh SH; Edis Z; Sharifi M; Kachooei E; Falahati M
J Biomol Struct Dyn; 2021 Jul; 39(10):3780-3786. PubMed ID: 32397951
[TBL] [Abstract][Full Text] [Related]
11. ACE2 protein expression in lung tissues of severe COVID-19 infection.
Gheware A; Ray A; Rana D; Bajpai P; Nambirajan A; Arulselvi S; Mathur P; Trikha A; Arava S; Das P; Mridha AR; Singh G; Soneja M; Nischal N; Lalwani S; Wig N; Sarkar C; Jain D
Sci Rep; 2022 Mar; 12(1):4058. PubMed ID: 35260724
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
Sabater Molina M; Nicolás Rocamora E; Bendicho AI; Vázquez EG; Zorio E; Rodriguez FD; Gil Ortuño C; Rodríguez AI; Sánchez-López AJ; Jara Rubio R; Moreno-Docón A; Marcos PJ; García Pavía P; Villa RB; Gimeno Blanes JR
PLoS One; 2022; 17(2):e0263140. PubMed ID: 35120165
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery.
Song J; Zhu J; Chen W; Zhu G; Wang W; Chen C; Jia Z; Zha Y; Xu P; Wang Z; Sun F; Zhang X
Aging (Albany NY); 2020 Nov; 13(8):10821-10832. PubMed ID: 33234728
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
[TBL] [Abstract][Full Text] [Related]
16. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H
J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084
[TBL] [Abstract][Full Text] [Related]
17. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell Expression Landscape of SARS-CoV-2 Receptor
Han G; Sinjab A; Hara K; Treekitkarnmongkol W; Brennan P; Chang K; Bogatenkova E; Sanchez-Espiridion B; Behrens C; Solis LM; Gao B; Girard L; Zhang J; Sepesi B; Cascone T; Byers LA; Gibbons DL; Chen J; Moghaddam SJ; Ostrin EJ; Scheet P; Fujimoto J; Shay J; Heymach JV; Minna JD; Dubinett S; Wistuba II; Stevenson CS; Spira AE; Wang L; Kadara H
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809063
[TBL] [Abstract][Full Text] [Related]
19. The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection.
Shen Q; Xiao X; Aierken A; Yue W; Wu X; Liao M; Hua J
J Cell Mol Med; 2020 Aug; 24(16):9472-9477. PubMed ID: 32594644
[TBL] [Abstract][Full Text] [Related]
20. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
